Based on the gene expression profile, four molecular subtypes have been identified for breast cancer which are luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and basal-like (triple negative) [27]. Here, ERBB2 is linked to breast carcinoma.